The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Eluting Catheter-Global Market Insights and Sales Trends 2024
Synopsis
The global Drug Eluting Catheter market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Catheter in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Drug Eluting Catheter market. PTA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PTCA segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Catheter, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Catheter market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Catheter market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Catheter sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Catheter covered in this report include Boston Scientific Corporation, Medtronic, BD, Aesculap, Philips, Biotronik, Aachen Resonance, iVascular and Acrostak, etc.
The global Drug Eluting Catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Medtronic
BD
Aesculap
Philips
Biotronik
Aachen Resonance
iVascular
Acrostak
Global Drug Eluting Catheter market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Catheter market, Segment by Type:
PTA
PTCA
Global Drug Eluting Catheter market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Catheter manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Drug Eluting Catheter market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Catheter in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Drug Eluting Catheter market. PTA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PTCA segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Catheter, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Catheter market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Catheter market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Catheter sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Catheter covered in this report include Boston Scientific Corporation, Medtronic, BD, Aesculap, Philips, Biotronik, Aachen Resonance, iVascular and Acrostak, etc.
The global Drug Eluting Catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Medtronic
BD
Aesculap
Philips
Biotronik
Aachen Resonance
iVascular
Acrostak
Global Drug Eluting Catheter market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Catheter market, Segment by Type:
PTA
PTCA
Global Drug Eluting Catheter market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Catheter manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Drug Eluting Catheter Market Overview
1.1 Drug Eluting Catheter Product Overview
1.2 Drug Eluting Catheter Market Segment by Type
1.2.1 PTA
1.2.2 PTCA
1.3 Global Drug Eluting Catheter Market Size by Type
1.3.1 Global Drug Eluting Catheter Market Size Overview by Type (2018-2029)
1.3.2 Global Drug Eluting Catheter Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drug Eluting Catheter Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Eluting Catheter Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drug Eluting Catheter Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drug Eluting Catheter Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drug Eluting Catheter Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drug Eluting Catheter Sales Breakdown by Type (2018-2023)
2 Global Drug Eluting Catheter Market Competition by Company
2.1 Global Top Players by Drug Eluting Catheter Sales (2018-2023)
2.2 Global Top Players by Drug Eluting Catheter Revenue (2018-2023)
2.3 Global Top Players by Drug Eluting Catheter Price (2018-2023)
2.4 Global Top Manufacturers Drug Eluting Catheter Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Catheter Market Competitive Situation and Trends
2.5.1 Drug Eluting Catheter Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Catheter Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Catheter as of 2022)
2.7 Date of Key Manufacturers Enter into Drug Eluting Catheter Market
2.8 Key Manufacturers Drug Eluting Catheter Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Catheter Status and Outlook by Region
3.1 Global Drug Eluting Catheter Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drug Eluting Catheter Historic Market Size by Region
3.2.1 Global Drug Eluting Catheter Sales in Volume by Region (2018-2023)
3.2.2 Global Drug Eluting Catheter Sales in Value by Region (2018-2023)
3.2.3 Global Drug Eluting Catheter Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drug Eluting Catheter Forecasted Market Size by Region
3.3.1 Global Drug Eluting Catheter Sales in Volume by Region (2024-2029)
3.3.2 Global Drug Eluting Catheter Sales in Value by Region (2024-2029)
3.3.3 Global Drug Eluting Catheter Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drug Eluting Catheter by Application
4.1 Drug Eluting Catheter Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Drug Eluting Catheter Market Size by Application
4.2.1 Global Drug Eluting Catheter Market Size Overview by Application (2018-2029)
4.2.2 Global Drug Eluting Catheter Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drug Eluting Catheter Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Catheter Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drug Eluting Catheter Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drug Eluting Catheter Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drug Eluting Catheter Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drug Eluting Catheter Sales Breakdown by Application (2018-2023)
5 North America Drug Eluting Catheter by Country
5.1 North America Drug Eluting Catheter Historic Market Size by Country
5.1.1 North America Drug Eluting Catheter Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drug Eluting Catheter Sales in Volume by Country (2018-2023)
5.1.3 North America Drug Eluting Catheter Sales in Value by Country (2018-2023)
5.2 North America Drug Eluting Catheter Forecasted Market Size by Country
5.2.1 North America Drug Eluting Catheter Sales in Volume by Country (2024-2029)
5.2.2 North America Drug Eluting Catheter Sales in Value by Country (2024-2029)
6 Europe Drug Eluting Catheter by Country
6.1 Europe Drug Eluting Catheter Historic Market Size by Country
6.1.1 Europe Drug Eluting Catheter Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drug Eluting Catheter Sales in Volume by Country (2018-2023)
6.1.3 Europe Drug Eluting Catheter Sales in Value by Country (2018-2023)
6.2 Europe Drug Eluting Catheter Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Catheter Sales in Volume by Country (2024-2029)
6.2.2 Europe Drug Eluting Catheter Sales in Value by Country (2024-2029)
7 Asia-Pacific Drug Eluting Catheter by Region
7.1 Asia-Pacific Drug Eluting Catheter Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Catheter Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drug Eluting Catheter Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drug Eluting Catheter Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drug Eluting Catheter Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Catheter Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drug Eluting Catheter Sales in Value by Region (2024-2029)
8 Latin America Drug Eluting Catheter by Country
8.1 Latin America Drug Eluting Catheter Historic Market Size by Country
8.1.1 Latin America Drug Eluting Catheter Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drug Eluting Catheter Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drug Eluting Catheter Sales in Value by Country (2018-2023)
8.2 Latin America Drug Eluting Catheter Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Catheter Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drug Eluting Catheter Sales in Value by Country (2024-2029)
9 Middle East and Africa Drug Eluting Catheter by Country
9.1 Middle East and Africa Drug Eluting Catheter Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Catheter Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drug Eluting Catheter Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drug Eluting Catheter Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drug Eluting Catheter Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Catheter Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drug Eluting Catheter Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boston Scientific Corporation
10.1.1 Boston Scientific Corporation Company Information
10.1.2 Boston Scientific Corporation Introduction and Business Overview
10.1.3 Boston Scientific Corporation Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boston Scientific Corporation Drug Eluting Catheter Products Offered
10.1.5 Boston Scientific Corporation Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Drug Eluting Catheter Products Offered
10.2.5 Medtronic Recent Development
10.3 BD
10.3.1 BD Company Information
10.3.2 BD Introduction and Business Overview
10.3.3 BD Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Drug Eluting Catheter Products Offered
10.3.5 BD Recent Development
10.4 Aesculap
10.4.1 Aesculap Company Information
10.4.2 Aesculap Introduction and Business Overview
10.4.3 Aesculap Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Aesculap Drug Eluting Catheter Products Offered
10.4.5 Aesculap Recent Development
10.5 Philips
10.5.1 Philips Company Information
10.5.2 Philips Introduction and Business Overview
10.5.3 Philips Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Philips Drug Eluting Catheter Products Offered
10.5.5 Philips Recent Development
10.6 Biotronik
10.6.1 Biotronik Company Information
10.6.2 Biotronik Introduction and Business Overview
10.6.3 Biotronik Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biotronik Drug Eluting Catheter Products Offered
10.6.5 Biotronik Recent Development
10.7 Aachen Resonance
10.7.1 Aachen Resonance Company Information
10.7.2 Aachen Resonance Introduction and Business Overview
10.7.3 Aachen Resonance Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aachen Resonance Drug Eluting Catheter Products Offered
10.7.5 Aachen Resonance Recent Development
10.8 iVascular
10.8.1 iVascular Company Information
10.8.2 iVascular Introduction and Business Overview
10.8.3 iVascular Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.8.4 iVascular Drug Eluting Catheter Products Offered
10.8.5 iVascular Recent Development
10.9 Acrostak
10.9.1 Acrostak Company Information
10.9.2 Acrostak Introduction and Business Overview
10.9.3 Acrostak Drug Eluting Catheter Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Acrostak Drug Eluting Catheter Products Offered
10.9.5 Acrostak Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Catheter Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Catheter Industrial Chain Analysis
11.4 Drug Eluting Catheter Market Dynamics
11.4.1 Drug Eluting Catheter Industry Trends
11.4.2 Drug Eluting Catheter Market Drivers
11.4.3 Drug Eluting Catheter Market Challenges
11.4.4 Drug Eluting Catheter Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Catheter Distributors
12.3 Drug Eluting Catheter Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
